Literature DB >> 23401103

Key articles and guidelines in the acute management and secondary prevention of ischemic stroke.

William L Baker1, Joel C Marrs, Lindsay E Davis, Edith A Nutescu, A Shaun Rowe, Melody Ryan, Michele Y Splinter, Orly Vardeny, Susan C Fagan.   

Abstract

Ischemic stroke is a prevalent disease with a large burden on the health system. It is essential for practitioners caring for patients who have experienced an ischemic stroke to be familiar with the literature supporting both acute management as well as secondary preventive strategies. Due to the large amount of literature available on this topic, this bibliography (the second of a two-part series) aims to provide a comprehensive resource for medical practitioners charged with caring for this population. Acute management strategies involve controlling patients' blood pressure and administering thrombolysis (either pharmacologic or mechanical) to improve blood flow and preserve neurologic function. Various neuroprevention strategies have also been investigated. Secondary prevention strategies, similar to primary prevention, focus on modulation of various risk factors including antiplatelet treatments and control of blood pressure, and lipid levels, amongst others.
© 2013 Pharmacotherapy Publications, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23401103     DOI: 10.1002/phar.1252

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  2 in total

1.  Gelatin nanoparticles enhance the neuroprotective effects of intranasally administered osteopontin in rat ischemic stroke model.

Authors:  Elizabeth Joachim; Il-Doo Kim; Yinchuan Jin; Kyekyoon Kevin Kim; Ja-Kyeong Lee; Hyungsoo Choi
Journal:  Drug Deliv Transl Res       Date:  2014-12       Impact factor: 4.617

2.  Therapeutic Effects of Policosanol and Atorvastatin against Global Brain Ischaemia-Reperfusion Injury in Gerbils.

Authors:  V Molina; Y Ravelo; M Noa; R Mas; Y Pérez; A Oyarzábal; N Mendoza; M Valle; S Jiménez; J Sánchez
Journal:  Indian J Pharm Sci       Date:  2013-11       Impact factor: 0.975

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.